Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Onconova Therapeutics, Inc. | Chief Science Officer Virology | Common Stock | 97.5K | $87.8K | $0.90 | Apr 1, 2024 | Direct |
Onconova Therapeutics, Inc. | Chief Science Officer Virology | Stock Option (right to purchase) | 503K | Apr 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 3 | $0 | 4 | Apr 3, 2024 | Chief Science Officer Virology |
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Chief Science Officer Virology |